196 related articles for article (PubMed ID: 281573)
1. A quantitative dosing schedule for the induction of transitional cell carcinomas in female F344 rats with the use of N-butyl-N-(4-hydroxybutyl)nitrosamine.
Becci PJ; Thompson HJ; Grubbs CJ; Moon RC
J Natl Cancer Inst; 1979 Jan; 62(1):187-91. PubMed ID: 281573
[No Abstract] [Full Text] [Related]
2. Synergistic effect of urinary bladder carcinogenesis in rats treated with N-butyl-n-(4-hydroxybutyl)nitrosamine, N-(4-(5-nitro-2-furyl)-2-thiazolyl)formamide,N-2-fluorenylacetamide, and 3,3'-dichlorobenzidine.
Tsuda H; Miyata Y; Murasaki G; Kinoshita H; Fukushima S
Gan; 1977 Apr; 68(2):183-92. PubMed ID: 892292
[No Abstract] [Full Text] [Related]
3. Dose response of saccharin in induction of urinary bladder hyperplasias in Fischer 344 rats pretreated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Nakanishi K; Hagiwara A; Shibata M; Imaida K; Tatematsu M; Ito N
J Natl Cancer Inst; 1980 Nov; 65(5):1005-10. PubMed ID: 6933236
[TBL] [Abstract][Full Text] [Related]
4. Trisodium nitriloacetate monohydrate: promoting effect in urinary bladder carcinogenesis in rats treated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Hiasa Y; Kitahori Y; Konishi N; Shimoyama T; Miyashiro A
J Natl Cancer Inst; 1985 Jan; 74(1):235-9. PubMed ID: 3855482
[TBL] [Abstract][Full Text] [Related]
5. Induction of tumors in heterotopic bladder by topical application of N-methyl-N-nitrosourea and N-butyl-N-(3-carboxypropyl)nitrosamine.
Oyasu R; Iwasaki T; Matsumoto M; Hirao Y; Tabuchi Y
Cancer Res; 1978 Sep; 38(9):3019-25. PubMed ID: 679209
[TBL] [Abstract][Full Text] [Related]
6. The diverse modification of N-butyl-N-(4-hydroxybutyl) nitrosamine induced carcinogenesis in urinary bladder by dibromodulcitol and dianhydrodulcitol.
Szende B; Jeney A; Institoris L
Acta Morphol Hung; 1992; 40(1-4):187-93. PubMed ID: 1365762
[TBL] [Abstract][Full Text] [Related]
7. [Effect of reduced glutathione on N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced urinary bladder cancer in rats].
Komatsu H; Kakizoe T; Nishio Y; Honma Y; Niijima T
Nihon Hinyokika Gakkai Zasshi; 1983 Dec; 74(12):2077-80. PubMed ID: 6677790
[No Abstract] [Full Text] [Related]
8. Induction of urinary bladder tumors in rats by administration nitrosomethyldodecylamine.
Lijinsky W; Taylor HW
Cancer Res; 1975 Apr; 35(4):958-61. PubMed ID: 1116153
[TBL] [Abstract][Full Text] [Related]
9. [Animal models of bladder cancer].
Fukushima S
Hinyokika Kiyo; 1988 Nov; 34(11):1923-7. PubMed ID: 3242366
[TBL] [Abstract][Full Text] [Related]
10. Effect of vitamin A acetate on urinary bladder carcinogenesis induced by N-butyl-N-(4-hydroxybutyl)nitrosamine in rats.
Miyata Y; Tsuda H; Matayoshi-Miyasato K; Fukushima S; Murasaki G; Ogiso T; Ito N
Gan; 1978 Dec; 69(6):845-8. PubMed ID: 750276
[TBL] [Abstract][Full Text] [Related]
11. 13-cis-Retinoic acid: inhibition of bladder carcinogenesis induced in rats by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Grubbs CJ; Moon RC; Squire RA; Farrow GM; Stinson SF; Goodman DG; Brown CC; Sporn MB
Science; 1977 Nov; 198(4318):743-4. PubMed ID: 910158
[TBL] [Abstract][Full Text] [Related]
12. Strong promoting activity of reversible uracil-induced urolithiasis on urinary bladder carcinogenesis in rats initiated with N-butyl-N-(4-hydroxybutyl)nitrosamine.
Shirai T; Tagawa Y; Fukushima S; Imaida K; Ito N
Cancer Res; 1987 Dec; 47(24 Pt 1):6726-30. PubMed ID: 3677102
[TBL] [Abstract][Full Text] [Related]
13. Effect of delay in administration of 13-cis-retinoic acid on the inhibition of urinary bladder carcinogenesis in the rat.
Becci PJ; Thompson HJ; Grubbs CJ; Brown CC; Moon RC
Cancer Res; 1979 Aug; 39(8):3141-4. PubMed ID: 455298
[TBL] [Abstract][Full Text] [Related]
14. Effect of intravesical instillation of antitumor drugs in the development of N-butyl-N-(4-hydroxybutyl) nitrosamine-induced bladder tumors in rats.
Suzuki T; Imai K; Takezawa Y; Tsuji H; Yamanaka H; Suzuki K
Hinyokika Kiyo; 1989 Feb; 35(2):247-51. PubMed ID: 2735235
[TBL] [Abstract][Full Text] [Related]
15. Aging and urinary bladder carcinogenesis induced in rats by N-butyl-N-(4-hydroxybutyl)nitrosamine.
Fukushima S; Shibata M; Tamano S; Ito N; Suzuki E; Okada M
J Natl Cancer Inst; 1987 Aug; 79(2):263-7. PubMed ID: 3474459
[TBL] [Abstract][Full Text] [Related]
16. Stages of transformation in the development of N-butyl-N-(4-hydroxybutyl)-nitrosamine-induced transitional cell carcinomas in the urinary bladder of rats.
Kunze E; Schauer A; Schatt S
Z Krebsforsch Klin Onkol Cancer Res Clin Oncol; 1976; 87(2):139-60. PubMed ID: 136822
[TBL] [Abstract][Full Text] [Related]
17. Early changes caused by N-butyl-N-(4-hydroxybutyl)nitrosamine in the bladder epithelium of different animal species.
Ito N
Cancer Res; 1976 Jul; 36(7 PT 2):2528-31. PubMed ID: 1277162
[No Abstract] [Full Text] [Related]
18. [A model of rat's urinary bladder tumor induced by subcutaneous injection of N-butyl-N-(4-hydroxybutyl)-nitrosamine].
Pliss GB; Vlasov NN; Iogannsen MG; Frolov AG
Vopr Onkol; 1998; 44(4):432-5. PubMed ID: 9807207
[TBL] [Abstract][Full Text] [Related]
19. Patterns of epithelial proliferation revealed by continuous administration of bromodeoxyuridine during urinary bladder carcinogenesis in rats.
Tatematsu M; Fukushima S; Aoki T; Mera Y; Inoue T; Ito N
Jpn J Cancer Res; 1987 Sep; 78(9):879-82. PubMed ID: 3117745
[TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of 13-cis-retinoic acid on urinary bladder carcinogenesis induced in C57BL/6 mice by N-butyl-N-(4-hydroxybutyl)-nitrosamine.
Becci PJ; Thompson HJ; Grubbs CJ; Squire RA; Brown CC; Sporn MB; Moon RC
Cancer Res; 1978 Dec; 38(12):4463-6. PubMed ID: 719631
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
